# Aurobindo Pharma Limited, Polepally, Mahaboob Nagar, India – FDA Inspections

Source: https://www.keypedia.com/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76

> Inspection records and compliance data for Aurobindo Pharma Limited in Polepally, Mahaboob Nagar. 9 FDA inspections on record (1 OAI), 2 Form 483s, last inspected February 10, 2026.

---

## Details

- Name: Aurobindo Pharma Limited
- FEI Number: 3007373532
- Facility Type: Finished Product Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: Unit Vii, Formulation Plant, Green Industrial Park, 411/P, 425/P, 434/P, 435/P & 458/P, Plot No.S1 (Part) Sez (Pharma), Tsiic
- City: Polepally, Mahaboob Nagar
- Country Name: India
- Address: Unit Vii, Formulation Plant, Green Industrial Park, 411/P, 425/P, 434/P, 435/P & 458/P, Plot No.S1 (Part) Sez (Pharma), Tsiic, Polepally, Mahaboob Nagar, India
- Country: India

## Related Documents

- [483 - Aurobindo Pharma Limited - 2026-02-10](https://www.keypedia.com/records/483/aurobindo-pharma-limited/fa93be5a-0031-4676-b411-4813d0c7f1aa) — source: FDA, date: February 10, 2026
- [FDA Inspection 1304312 - Aurobindo Pharma Limited - 2026-02-10](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/f603cc93-dc47-4606-8cf0-0dde6af906da) — source: FDA, date: February 10, 2026
- FDA Inspection 1242351 - Aurobindo Pharma Limited - 2023-08-04 — source: FDA, date: August 4, 2023
- [483 - Aurobindo Pharma Limited - 2022-05-10](https://www.keypedia.com/records/483/aurobindo-pharma-limited/cdc2cd57-b94d-4778-9f26-a81d8d0d6db3) — source: FDA, date: May 10, 2022
- [FDA Inspection 1169446 - Aurobindo Pharma Limited - 2022-05-10](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/b9201ac7-5ec4-46dd-8aaf-7304c3c93094) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2022
- [483 - Aurobindo Pharma Limited - 2019-09-27](https://www.keypedia.com/records/483/aurobindo-pharma-limited/7bfb2b5e-0991-4dcb-861b-ef0d934ade3d) — source: FDA, date: September 27, 2019
- [FDA Inspection 1105823 - Aurobindo Pharma Limited - 2019-09-27](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/65ccbba1-8a36-41aa-99c4-64321edccdd9) — classification: Official Action Indicated (OAI), source: FDA, date: September 27, 2019
- FDA Inspection 1022788 - Aurobindo Pharma Limited - 2017-06-24 — classification: No Action Indicated (NAI), source: FDA, date: June 24, 2017
- FDA Inspection 927596 - Aurobindo Pharma Limited - 2015-03-13 — classification: No Action Indicated (NAI), source: FDA, date: March 13, 2015
- FDA Inspection 787128 - Aurobindo Pharma Limited - 2012-06-19 — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012
- [FDA Inspection 694644 - Aurobindo Pharma Limited - 2010-07-30](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/e2ec8cd8-27f8-4bb8-a70f-248992e68a88) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 30, 2010
- FDA Inspection 636493 - Aurobindo Pharma Limited - 2009-10-13 — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2009

## Related Companies

- [Zydus Pharmaceuticals Limited](https://www.keypedia.com/companies/zydus-pharmaceuticals-limited/a915c687-5359-4e95-b6bc-b2e6a506ca52)
- [Apotex Research Private Limited](https://www.keypedia.com/companies/apotex-research-private-limited/074db0b0-4f5f-4ee7-90e9-1c661c86f90c)
- [Cardinal Health 414, LLC](https://www.keypedia.com/companies/cardinal-health-414-llc/b1d6d59b-695c-42a4-8272-d3e5a96de306)
- [SpecGx, LLC](https://www.keypedia.com/companies/specgx-llc/ee069c18-3128-4bbe-9c13-768b4837810f)
- [Quotient Sciences - Philadelphia, LLC](https://www.keypedia.com/companies/quotient-sciences-philadelphia-llc/21968347-fe31-4ffc-801c-5253fa909968)
- [United Therapeutic Corporation](https://www.keypedia.com/companies/united-therapeutic-corporation/fda8d6ce-d684-4496-89b6-5f8b526d83f7)
- [Alnylam Pharmaceuticals Inc.](https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/285be436-d642-438b-ac4c-530088c678b8)
- [Conopco Inc. d/b/a Unilever](https://www.keypedia.com/companies/conopco-inc-dba-unilever/f742261e-b37a-43b6-afd4-98d63b24d0da)
- [Iso-Tex Diagnostics, Inc.](https://www.keypedia.com/companies/iso-tex-diagnostics-inc/59c59676-32cc-4749-b95d-3bdc31559b58)
- [Amneal Complex Products Research LLC](https://www.keypedia.com/companies/amneal-complex-products-research-llc/a2be8996-ba6b-481d-b935-b75129500758)

## Related Officers

- [Compliance Officer at FDA](https://www.keypedia.com/people/emmanuel-j-ramos/ba0666bd-2752-453e-9fd3-5e43b1cff3ad)
- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [Consumer Safety Officer](https://www.keypedia.com/people/darren-s-brown/389a4d1f-7f34-42cd-bdc8-5bebd41aff56)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Investigator](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)
- [Nibin Varghese](https://www.keypedia.com/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)
